SEC Being Misled In CBD Fraud Fight, CEO Claims
By Jonathan Capriel · October 23, 2025, 6:25 PM EDT
The U.S. Securities and Exchange Commission has "unwittingly" taken the side of a former partner with a terminated licensing agreement, a pharmaceutical CEO told a California federal court this week, asking...
To view the full article, register now.